Termination of the Bendamustine Hydrochloride Technology Licensing-Out Agreement with シンバイオ製薬

A termination event involving certain region-specific licensing agreements for bendamustine hydrochloride, in which the technology licensing-out agreement with シンバイオ製薬 covering China was terminated, followed by termination of the agreement covering South Korea, Taiwan and Singapore.